Pediatrix Medical Group Inc. (MD)
NYSE
28.10
+0.02 (+0.07%)
Closed
Oct 21, 2026
Day's Range
27.5428.23
52 wk Range
16.8228.29
Financial Statements - MD - Pediatrix Medical Group Inc.
Revenue
1.91B▼ 4.9%
Net Income
165.38M▲ 266.9%Net Margin 8.6%
EBITDA
256.54M▲ 17.5%
Free Cash Flow
252.63M▲ 36.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.91B | 2.01B | 1.99B | 1.97B | 1.91B | 1.73B |
| Cost of Goods | 1.42B | 1.55B | 1.57B | 1.50B | 1.39B | 1.28B |
| Gross Profit | 493.70M | 454.34M | 421.56M | 467.03M | 513.24M | 449.32M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 231.08M | 183.68M | 157.85M | 200M | 217.73M | 171.93M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 21.31M | -244.27M | -164.13M | -78.93M | -13.78M | -54.30M |
| Pre Tax Income | 216.43M | -101.34M | -48.35M | 81.37M | 135.22M | 7.14M |
| Income Tax | 51.04M | -2.27M | 12.04M | 18.80M | 27.24M | 16.72M |
| Net Income | 165.38M | -99.06M | -60.40M | 66.33M | 130.93M | -796.48M |
| EPS Basic | 1.9932 | -1.153763 | -0.718989 | 0.799728 | 1.515384 | -9.305527 |
| EPS Diluted | 1.94 | -1.19 | -0.73 | 0.79 | 1.515384 | -9.55 |
| Basic Shares Outstanding | 82.97M | 85.86M | 84.01M | 82.94M | 86.42M | 85.59M |
| Diluted Shares Outstanding | 82.97M | 85.86M | 84.01M | 82.94M | 86.42M | 85.59M |
| Ebit | 252.39M | -60.59M | -6.28M | 121.06M | 203.95M | 117.63M |
| Ebitda | 256.54M | 218.25M | 196.08M | 237.35M | 251.79M | 201.95M |
| Net Income Continuous Operations | 165.38M | -99.06M | -60.40M | 62.56M | 108.01M | -9.58M |
| Minority Interests | - | 0 | 0 | 4K | 27K | 0 |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
